Fig. 5
From: Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
SKL2001 reversed the effects of Sevoflurane on Wnt/β-catenin Signaling. A-F. Western blotting and RT-qPCR detected the protein and mRNA expression of Wnt3a, β-catenin, p-GSK3β, GSK3β, c-Myc, and Cyclin D1 in TFK1 cells; G-L. Western blotting and RT-qPCR detected the protein and mRNA expression of Wnt3a, β-catenin, p-GSK3β, GSK3β, c-Myc, and Cyclin D1 in QBC939 cells. **p < 0.01 vs. control group; #, ##p < 0.05, 0.01 vs. Sevoflurane treatment group